2010. Swiss Consensus Statement: Recommendations for optimising re-treatment with MabThera® (rituximab) in rheumatoid arthritis. Swiss Medical Weekly. 140, 2728 (Jul. 2010), w13073. DOI:https://doi.org/10.4414/smw.2010.13073.